| abstract |
Compositions for treating, reducing, ameliorating, or alleviating symptoms or diseases behind the eyes caused by inflammation include a dissociated glucocorticoid receptor agonist (“DIGRA”). The composition can also include other anti-inflammatory agents, or anti-angiogenic agents, or combinations thereof. The composition can be formulated for topical application, injection, implantation. The composition can be administered alone or in combination with other procedures selected to improve treatment outcome. |